BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 2020;183:999-1010. [PMID: 33048349 DOI: 10.1111/bjd.19556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Odorici G, Pacetti L, Forconi R, Schettini N, Zedde P, Corazza M, Bettoli V. Seven Years-Experience of adalimumab therapy for hidradenitis suppurativa in a real-life dermatologic setting. J Dermatolog Treat 2021;:1-10. [PMID: 33843413 DOI: 10.1080/09546634.2021.1914309] [Reference Citation Analysis]
2 Johnston DGW, Kirby B, Tobin DJ. Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction? Exp Dermatol 2021;30:1554-68. [PMID: 34418166 DOI: 10.1111/exd.14451] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu Y, Fu H, Yang X, Leng F, Huang Y, Deng H, Xiang Q, Zhang S. Polygalaxanthone III downregulates inflammation in the lipopolysaccharide-stimulated RAW264.7 macrophages: A quantibody array analysis. J Pharmacol Sci 2021;147:184-91. [PMID: 34384566 DOI: 10.1016/j.jphs.2021.06.010] [Reference Citation Analysis]
4 Corazza M, Schettini N, Zedde P, Borghi A. Vulvar Lichen Sclerosus from Pathophysiology to Therapeutic Approaches: Evidence and Prospects. Biomedicines 2021;9:950. [PMID: 34440154 DOI: 10.3390/biomedicines9080950] [Reference Citation Analysis]
5 Wolk K, Brembach T, Šimaitė D, Bartnik E, Cucinotta S, Pokrywka A, Irmer M, Triebus J, Witte‐händel E, Salinas G, Leeuw T, Volk H, Ghoreschi K, Sabat R. Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*. Br J Dermatol 2021;185:164-76. [DOI: 10.1111/bjd.19795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
6 Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ, Jemec GBE, Del Marmol V, Marzano AV, Nikolakis G, Sayed CJ, Tzellos T, Wolk K, Prens EP. Target molecules for future hidradenitis suppurativa treatment. Exp Dermatol 2021;30 Suppl 1:8-17. [PMID: 34085329 DOI: 10.1111/exd.14338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
7 Del Duca E, Morelli P, Bennardo L, Di Raimondo C, Nisticò SP. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. Int J Mol Sci 2020;21:E8436. [PMID: 33182701 DOI: 10.3390/ijms21228436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
8 Alishahedani ME, Yadav M, McCann KJ, Gough P, Castillo CR, Matriz J, Myles IA. Therapeutic candidates for keloid scars identified by qualitative review of scratch assay research for wound healing. PLoS One 2021;16:e0253669. [PMID: 34143844 DOI: 10.1371/journal.pone.0253669] [Reference Citation Analysis]
9 Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells 2021;10:2094. [PMID: 34440863 DOI: 10.3390/cells10082094] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Nikolakis G, Kokolakis G, Kaleta K, Wolk K, Hunger R, Sabat R, Zouboulis CC. [Pathogenesis of hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:658-65. [PMID: 34228138 DOI: 10.1007/s00105-021-04853-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhou P, Liu J, Xu T, Guo Y, Han Y, He Y, Lin L, Xiao X. Mutations in γ-secretase subunit-encoding PSENEN gene alone may not be sufficient for the development of acne inversa. J Dermatol Sci 2021:S0923-1811(21)00143-2. [PMID: 34330582 DOI: 10.1016/j.jdermsci.2021.06.007] [Reference Citation Analysis]
12 Schneider-Burrus S, Tsaousi A, Barbus S, Huss-Marp J, Witte K, Wolk K, Fritz B, Sabat R. Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients. Front Med (Lausanne) 2021;8:676241. [PMID: 33987196 DOI: 10.3389/fmed.2021.676241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Barrea L, Muscogiuri G, Pugliese G, de Alteriis G, Maisto M, Donnarumma M, Tenore GC, Colao A, Fabbrocini G, Savastano S. Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa). Nutrients 2021;13:1997. [PMID: 34200594 DOI: 10.3390/nu13061997] [Reference Citation Analysis]